Janet Woodcock would continue tackling issues including bogus COVID-19 claims and heavy metals in baby food if nominated as FDA commissioner, says former head Scott Gottlieb. He praises Woodcock’s “great judgment” and her view on policy that will “expand across the agency.”
Former commissioner Scott Gottlieb doesn’t see a “plan B” for US Food and Drug Administration leadership beyond Janet Woodcock being moved from acting to permanent commissioner.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
Testing conducted by the US Food and Drug Administration has found several cosmetic products on the market that contain high levels of methylene chloride, a banned ingredient.
Major Europe-based consumer health players Haleon, Reckitt and Bayer feature in this sales and earnings preview, which highlights what to look out for as these three firms report their Q1 2025 results over the coming weeks.
The preliminary White House 2026 budget plan cuts agency funding, but not so sharply that user fees are excluded from collection.
